New Delhi: A new study suggests that the blockbuster diabetes drug Semaglutide could be sold for a profit at just $0.89 (Rs 83.35) a month compared to $353 (Rs 29,421) currently charged in the US, highlighting “exorbitant corporate profiteering” by pharmaceutical companies when it comes to such medicines. According to an analysis by Doctors Without … Read more
Home Health Moringa For Diabetes: Do Drumstick Leaves Help Manage Blood Sugar Levels? All You Need to Know Diabetes tends to fluctuate during the winter season. Diet plays a pivotal role and moringa leaves can be a good addition for diabetics. Here is how it may be beneficial for blood sugar control. Moringa For Diabetes: … Read more
New Delhi: The Central Drugs Standard Control Organisation (CDSCO) has rejected Danish pharma giant Novo Nordisk’s application to import and sell a treatment touted as the world’s first weekly insulin, ThePrint has learnt. The drug regulator has asked the pharmaceutical giant for more details about the drug, which is not yet approved anywhere, including the … Read more
This article is part of HuffPost’s biweekly politics newsletter. Click here to subscribe. Lots of Americans say they are prepared to vote against President Joe Biden in November. Among the many reasons seems to be a persistent belief that Biden has accomplished “not very much” or “little or nothing” (according to an ABC-Washington Post poll … Read more
NEW DELHI: Drug firm, USV and bio-tech company, Biogenomics announced the launch of INSUQUICK, India’s first biosimilar Insulin Aspart, in a bid to improve access for people with diabetes. InsuQuick is a “Make in India” product, developed and manufactured using 100% indigenous technology, and has undergone a robust clinical program to ensure global quality standards.a … Read more